1 results match your criteria: "China hBrighton and Sussex Medical School[Affiliation]"
Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.
J Hypertens
November 2016
aCenter for Life-Course Health Research/Geriatrics, University of Oulu bMedical Research Center Oulu, Oulu University Hospital cOulu City Hospital, Oulu, Finland dImperial College eGuys and St Thomas' NHS Trust, London, UK fHypertension Unit, Department of Cardiovascular Sciences, KU Leuven University, Leuven, Belgium gCentre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China hBrighton and Sussex Medical School, Brighton, UK.
Objective: We assessed the prognostic value of ECG left ventricular hypertrophy (LVH) using Sokolow-Lyon (SL-LVH), Cornell voltage (CV-LVH) or Cornell product (CP-LVH) criteria in 3043 hypertensive people aged 80 years and over enrolled in the Hypertension in the Very Elderly Trial.
Methods: Multivariate Cox proportional hazard models were used to estimate hazard ratios with 95% confidence intervals (CIs) for all-cause mortality, cardiovascular diseases, stroke and heart failure in participants with and without LVH at baseline. The mean follow-up was 2.